Enteral Feeding Formulas Market Share Growth Trends Report 2024-2031

Enteral Feeding Formulas Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Enteral Feeding Formulas Market is segmented&nbsp;By Product (Disease-specific Formulas, Standard Formulas),&nbsp;By Stage (Adults, Pediatrics),&nbsp;By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow),&nbsp;By Application (Oncology, Diabetes, Neurology, Gastroenterology, Critical Care, Others),&nbsp;By End-User (Hospitals, Homecare Agencies &amp; Hospices, Long-term Care Facilities, Nursing Homes, Others),&nbsp;and By Region (North America, South America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

&nbsp;

<h3>Enteral Feeding Formulas Market Overview</h3>

<blockquote>
Enteral Feeding Formulas Market is expected to reach at a CAGR of 6.8% during the forecast period 2024-2031.&nbsp;The global enteral feeding formulas market is dominated by the North America region, which holds the largest market share. The competitive&nbsp;rivalry intensifies with&nbsp;Abbott Laboratories,&nbsp;Fresenius Kabi AG, and Health Products, Inc.
</blockquote>

Enteral feeding is the delivery of a nutritionally complete feed containing fat, protein, minerals, carbohydrate, water, and vitamins, directly to the stomach, duodenum, or jejunum. There are various types of tubes available for enteral feed formulae, such as gastrostomy, nasojejunal tube, nasogastric tube, and jejunostomy. These tubes are made of silicone, <a href="https://www.datamintelligence.com/research-report/polyurethane-market" target="_blank">polyurethane</a>, or PVC and are of different lengths from 30 to 43 inches, with diameters from 8 to 14 inches for adults. Some of the other equipment used for enteral feeding include an administration reservoir (bottle, feed bag, etc.), syringes, and enteral pump. Various routes are used in the administration of the necessary nutrients are cost-effective, healthy, and also a choice for the invasive process. Enteral feeding is preferred for patients with malnutrition due to eating disorders such as anorexia nervosa, dysphagia, and stomach infections, among others.

<h3>Enteral Feeding Formulas Market Scope</h3>

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>
			6.8%
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Product,&nbsp;By Stage,&nbsp;By Flow Type,&nbsp;By Application,&nbsp;By End-User,&nbsp;and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more insights&nbsp;<a href="https://www.datamintelligence.com/download-sample/enteral-feeding-formulas-market" target="_blank">Download Sample</a>

&nbsp;

<h3>Enteral Feeding Formulas Market Dynamics</h3>

The demand for enteral feeding formula demand is surging with rising therapeutic uses of enteral feeding formula coupled with the introduction of new technologically advanced enteral feeding formula. In addition, the growing geriatric population globally and the rising prevalence of preterm births are also boosting the market growth.

The high prevalence rate of chronic disorders is driving the market growth

Increasing incidences of chronic disorders, such as cardiovascular diseases, cancer, diabetes, and (Coronary Obstructive Pulmonary Disorders) COPD are expected to drive the growth of the enteral feeding formulas market.

As per the International Diabetes Federation, diabetes patients spent US$ 966 billion in health expenditure in 2021, of which, 9 percent of total spending on adults. Around 537 million adults (20-79 years) are living with diabetes currently, and by 2045 this is projected to rise to 783 million. The proportion of type 2 diabetes people is increasing in most countries. Around 541 million adults&rsquo; people are at increased risk of developing type 2 diabetes. population was suffering from some form of cardiac disease; it is further estimated that this prevalence is likely to increase to 45% by 2035. According to the Centers for Disease Control and Prevention (CDC) of the U.S., about half of the population (47%) of the United States have at least one of these three risk factors.

For the treatment of these chronic diseases, a longer hospital stays and recovery time is required. Patients face problems in swallowing food, so, external nutrition is given to the patient through the tube. Hence, the increase in the cases of chronic diseases, such as cancer and cardiovascular diseases, is expected to drive the growth of the market over the forecast period.

Lack of reimbursement is hampering the growth of the enteral feeding formulas market

The lack of reimbursement of enteral feeding formula is expected to hamper the usage of enteral feeding formula and lower the adoption rate of the enteral feeding formula in the forecast period.

<h3>Enteral Feeding Formulas Market Segmentation Analysis</h3>

The global enteral feeding formulas market is segmented based on product, flow type, stage, application, and end-users.

The oncology segment is expected to hold a major market share in the enteral feeding formulas market

The burden of cancer is growing rapidly worldwide. Cancer is expected to grow rapidly during the forecast period. The WHO has reported that cancer is the second leading cause of death globally and is responsible for 10 million deaths or one death in 6 deaths in 2020 and worldwide. Also, around 70% of deaths from cancer occur in low and middle-income countries. WHO stated that around 17.9 million people die every year with cardiovascular diseases, and globally, it accounts for 32% of deaths. The majority of tumor-bearing patients suffer from cancer cachexia, which causes insulin resistance, increased lipolysis with loss of body fat, increased protein turnover, and loss of muscle mass, causing loss of appetite and weight.

Also, there are several complications and side effects in the patients while cancer treatment, including difficulty in chewing and swallowing solid food, mucositis sores in the mouth, altered saliva level, which makes it difficult to swallow. To improve the clinical condition of patients, delivery of nutrition is very difficult for the cancer patients to take the food orally, hence, the nutrition is supplied by enteral feeding tubes to help them maintain the body mass.

The standard formulas segment is expected to hold the largest market share during the forecast period

By product, the market is classified into standard and disease-specific formulas. Among these, the standard formulas segment accounted for the largest market share due to its high demand for enteral nutrition and basic clinical nutrition, high commercial availability, and growing investment by major companies. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas. There are different varieties of standard formulas available with the growing demand for low-cost nutrient formulations. The demand for standard tube feeds is high among volume-sensitive patients or patients with congestive heart failure, Syndrome of Inappropriate Diuretic Hormone (SIADH), and renal failure.

On the other hand, the disease-specific formulas are expected to grow at the fastest growth rate during the forecast period, 2020 to 2027 due to growing improvements in enteral feeding formula and devices with the rising prevalence of several chronic diseases. The disease-specific formulas segment is further segmented into renal, diabetic, hepatic, pulmonary, and others. Growing awareness among healthcare professionals and the patient population towards the benefits of enteral medical foods is one of the major factors driving the segment growth.

By Stage, the Adult Segment held the largest market share in 2019

Based on stage, the market is segmented into adults and pediatrics. The adult segment accounted for the largest market share in 2019, due to the growing adoption of tube feed among adults. The enteral feeding can be performed by the syringe method, gravity drip method, and pump method in adults. According to a study by the Medical Nutrition International Industry, the financial cost associated with malnutrition or undernutrition in the European Union is around US$ 185 billion. About one in six individuals are affected by malnutrition globally. The growing demand for such nutrition formulations in the adult population is one of the major factors boosting segment growth.

On the other hand, the pediatrics segment is expected to grow significantly over the forecast period, due to the rising number of premature births and increasing prevalence rate of malnutrition among hospitalized children. For instance, as per the report published by UNICEF-WHO-World Bank, more than one in five that is around 149.2 million children were stunted in 2020. Pediatric patients with a dysfunctional gastrointestinal tract cannot ingest nutrients orally and thus administer enteral feeding. Some pediatric patients suffering from gastrointestinal disorders, such as severe <a href="https://www.datamintelligence.com/research-report/gastroesophageal-reflux-disease-therapeutics-market" target="_blank">gastroesophageal reflux</a>, allergies, food refusal behavior, and metabolic disorders are also provided tube feeding.

By End-user, Home care is expected to grow significantly over the forecast period.

Home care is expected to grow at the fastest growth rate over the forecast period, owing to the rising number of patients receiving home enteral feeding with growing awareness towards balanced nutrition. There is a rise in the adoption of enteral feeding formulas among home healthcare patients. A policy was developed in combination with the National Institute for Clinical Excellence (NICE) which has revolutionized the healthcare service for patients on nutrition supplements and has enhanced the service delivery. 

<h3>Global Enteral Feeding Formulas Market Geographical Share</h3>

North America region holds the largest market share in the global enteral feeding formulas market

North America region is dominating the global enteral feeding formulas market accounted for the largest market share in 2021, due to several factors, such as the growing geriatric population, rising prevalence of preterm birth, and the increasing number of chronic disease patients. The United States is the major contributor to the growth of the enteral feeding formulas market. In the U.S., it is projected that the number of people aged above 65 years will more than double by 2060. The growing geriatric population would increase the cases of chronic diseases, such as cancer and diabetes, which will lead to an increase in the hospital stay of the patient. Also, according to the WHO, around 15 million babies are born preterm, and this number is rising. Hence, the market is expected to grow further in this region over the forecast period.

Asia-Pacific region is growing at the fastest CAGR during the forecast period.

The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period. The market in Japan, China, and India is likely to grow significantly during the forecast period, due to the large presence of patients suffering from chronic diseases and disorders, increasing incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, and growing demand in these countries.

<h3>Enteral Feeding Formulas Companies and Competitive Landscape</h3>

The enteral feeding formulas market is highly competitive with the presence of local as well as global companies.&nbsp; Some of the key players which are contributing to the growth of the market include Abbott Laboratories, Fresenius Kabi AG, B. Braun Melsungen AG, Victus, Inc., Hormel Food Corp., Danone S.A., Nestl&eacute; S.A., Mead Johnson Nutrition Company, Global Health Products, Inc., Meiji Holdings Co., Ltd., Trovita Health Science, among others.

B. Braun Melsungen AG

Overview:

B. Braun is majorly involved in the manufacturing, marketing, and distributing of various healthcare products and services in the fields of medical technology, medical services, and pharmaceutical products. The company&#39;s product range comprises around 5,000 products of which 95% of the products are manufactured by the company. Some of the major product lines manufactured by the company include disposables required for infusion, nutrition and pain therapy, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, and stoma and wound care products. B. Braun has a presence in 64 countries and develops products in 18 therapy fields of the healthcare industry. The company operates its business through five business divisions which include hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM), and other sales.

Product Portfolio:

Enteral Nutrition Pumps:

Enteroport&reg; plus: Enteral nutrition pump

Accessories Enteroport&reg; plus: Accessories for the enteral nutrition pump Enterport&reg; plus

Feeding Tubes

Nutritub&reg;: Polyurethane feeding tube

Gastric Tubes: Nasogastric and naso-intestinal PVC tubes for short-term use only.

Duodenal Tubes: PVC tube

Others

&nbsp;

<h3>Key Development</h3>

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Enteral Feeding Formulas market globally. For instance,

In June 2020, Hormel Foods has been named to the 100 Best Corporate Citizens list by 3BL Media, recognizing outstanding environmental, social, and governance (ESG) transparency and performance among the 1,000 largest U.S. public companies. This increases the credibility of the company and establishes a good name in the market

On 29th April 2022, Fresenius Kabi launched its new Enteral nutrition product app. That app is available for healthcare professionals in the United Kingdom and the Republic of Ireland.

<h3>COVID-19 Impact on&nbsp;Enteral Feeding Formulas Market</h3>

The demand for enteral feeding formulas is growing with the increasing number of COVID-19 cases in hospitals. In 2020, the critical care segment is rapidly growing in the enteral feeding formula industry due to the rising number of COVID-19 patients, which are also leading to the consumption of nutritional feeding formulas more towards the patients with ventilators.

Growing awareness among healthcare professionals regarding hospital-associated malnutrition is anticipated to boost the usage rate of enteral feeding formulas in hospitals. Moreover, the increasing number of ICU admissions during COVID-19, rising demand for enteral formulations among critically ill patients, are likely to boost the market growth.

&nbsp;

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	Methodology and Scope

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	Market Definition and Overview
	</li>
	<li>
	Executive Summary

	<ol>
		<li>
		Market Snippet by Product
		</li>
		<li>
		Market Snippet by Stage
		</li>
		<li>
		Market Snippet by Flow Type
		</li>
		<li>
		Market Snippet by Application
		</li>
		<li>
		Market Snippet by End-User
		</li>
		<li>
		Market Snippet by Region
		</li>
	</ol>
	</li>
	<li>
	Market Dynamics

	<ol>
		<li>
		Market Impacting Factors
		</li>
		<li>
		Drivers

		<ol>
			<li>
			Rising prevalence of chronic diseases and disorders
			</li>
			<li>
			Growing number of preterm births
			</li>
			<li>
			Technological advancement in feeding formulas
			</li>
			<li>
			XX
			</li>
		</ol>
		</li>
		<li>
		Restraints

		<ol>
			<li>
			Complications associated with enteral feeding
			</li>
			<li>
			XX
			</li>
		</ol>
		</li>
		<li>
		Opportunity
		</li>
		<li>
		Impact Analysis
		</li>
	</ol>
	</li>
	<li>
	Industry Analysis

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis
		</li>
		<li>
		Supply Chain Analysis
		</li>
		<li>
		Pricing Analysis
		</li>
		<li>
		Regulatory Analysis
		</li>
		<li>
		Reimbursement Analysis
		</li>
		<li>
		Unmet Needs
		</li>
	</ol>
	</li>
	<li>
	COVID-19 Analysis

	<ol>
		<li>
		Analysis of Covid-19 on the Market

		<ol>
			<li>
			Before COVID-19 Market Scenario
			</li>
			<li>
			Present COVID-19 Market Scenario
			</li>
			<li>
			After COVID-19 or Future Scenario
			</li>
		</ol>
		</li>
		<li>
		Pricing Dynamics Amid Covid-19
		</li>
		<li>
		Demand-Supply Spectrum
		</li>
		<li>
		Government Initiatives Related to the Market During Pandemic
		</li>
		<li>
		Manufacturers Strategic Initiatives
		</li>
		<li>
		Conclusion&nbsp;
		</li>
	</ol>
	</li>
	<li>
	By Product

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
			</li>
			<li>
			Market Attractiveness Index, By Product Segment
			</li>
		</ol>
		</li>
		<li>
		Disease-specific Formulas*

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
			<li>
			Pulmonary Formulas
			</li>
			<li>
			Diabetic Formulas
			</li>
			<li>
			Hepatic Formulas
			</li>
			<li>
			Renal Formulas
			</li>
			<li>
			Others
			</li>
		</ol>
		</li>
		<li>
		Standard Formulas

		<ol>
			<li>
			Monomeric Formulas
			</li>
			<li>
			Polymeric Formulas
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	By Stage

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage
			</li>
			<li>
			Market Attractiveness Index, By Stage Segment
			</li>
		</ol>
		</li>
		<li>
		Adults *

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Pediatrics
		</li>
	</ol>
	</li>
	<li>
	By Flow Type

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type
			</li>
			<li>
			Market Attractiveness Index, By Flow Type Segment
			</li>
		</ol>
		</li>
		<li>
		Intermittent Feeding Flow*

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Continuous Feeding Flow
		</li>
	</ol>
	</li>
	<li>
	By Application

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
			</li>
			<li>
			Market Attractiveness Index, By Application Segment
			</li>
		</ol>
		</li>
		<li>
		Oncology*

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Diabetes
		</li>
		<li>
		Neurology
		</li>
		<li>
		Gastroenterology
		</li>
		<li>
		Critical Care
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	By End-User

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
			</li>
			<li>
			Market Attractiveness Index, By End-User Segment
			</li>
		</ol>
		</li>
		<li>
		Hospitals*

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
		</ol>
		</li>
		<li>
		Homecare Agencies &amp; Hospices
		</li>
		<li>
		Long-term Care Facilities
		</li>
		<li>
		Nursing Homes
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	By Region

	<ol>
		<li>
		Introduction
		</li>
		<li>
		Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
		</li>
		<li>
		Market Attractiveness Index, By Region
		</li>
		<li>
		North America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				U.S.
				</li>
				<li>
				Canada
				</li>
				<li>
				Mexico
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Europe

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Germany
				</li>
				<li>
				U.K.
				</li>
				<li>
				France
				</li>
				<li>
				Italy
				</li>
				<li>
				Spain
				</li>
				<li>
				Rest of Europe
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		South America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Brazil
				</li>
				<li>
				Argentina
				</li>
				<li>
				Rest of South America
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Asia Pacific

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				China
				</li>
				<li>
				India
				</li>
				<li>
				Japan
				</li>
				<li>
				Australia
				</li>
				<li>
				Rest of Asia Pacific
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Middle East and Africa

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Flow Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Stage
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Competitive Landscape

	<ol>
		<li>
		Competitive Scenario
		</li>
		<li>
		Market Positioning/Share Analysis
		</li>
		<li>
		Mergers and Acquisitions Analysis
		</li>
	</ol>
	</li>
	<li>
	Company Profiles

	<ol>
		<li>
		Abbott Laboratories*

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Product Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		Fresenius Kabi AG
		</li>
		<li>
		B. Braun Melsungen AG
		</li>
		<li>
		Victus, Inc.
		</li>
		<li>
		Danone S.A.
		</li>
		<li>
		Nestl&eacute; S.A.
		</li>
		<li>
		Mead Johnson Nutrition Company
		</li>
		<li>
		Health Products, Inc.
		</li>
		<li>
		Meiji Holdings Co., Ltd.,
		</li>
		<li>
		Trovita Health Science (List Not Exhaustive)
		</li>
	</ol>
	</li>
	<li>
	DataM Intelligence

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables&nbsp;

Table 1 Global Enteral Feeding Formulas Market Value, By Product, 2023,2027 &amp; 2031 ($ Million)

Table 2 Global Enteral Feeding Formulas Market Value, By Stage, 2023,2027 &amp; 2031 ($ Million)

Table 3 Global Enteral Feeding Formulas Market Value, By Flow Type, 2023,2027 &amp; 2031 ($ Million)

Table 4 Global Enteral Feeding Formulas Market Value, By Application, 2023,2027 &amp; 2031 ($ Million)

Table 5 Global Enteral Feeding Formulas Market Value, By End-User, 2023,2027 &amp; 2031 ($ Million)

Table 6 Global Enteral Feeding Formulas Market Value, By Region, 2023,2027 &amp; 2031 ($ Million)

Table 7 Global Enteral Feeding Formulas Market Value, By Product, 2023,2027 &amp; 2031 ($ Million)

Table 8 Global Enteral Feeding Formulas Market Value, By Product, 2022-2031 ($ Million)

Table 9 Global Enteral Feeding Formulas Market Value, By Stage, 2023,2027 &amp; 2031 ($ Million)

Table 10 Global Enteral Feeding Formulas Market Value, By Stage, 2022-2031 ($ Million)

Table 11 Global Enteral Feeding Formulas Market Value, By Flow Type, 2023,2027 &amp; 2031 ($ Million)

Table 12 Global Enteral Feeding Formulas Market Value, By Flow Type, 2022-2031 ($ Million)

Table 13 Global Enteral Feeding Formulas Market Value, By Application, 2023,2027 &amp; 2031 ($ Million)

Table 14 Global Enteral Feeding Formulas Market Value, By Application, 2022-2031 ($ Million)

Table 15 Global Enteral Feeding Formulas Market Value, By End-User, 2023,2027 &amp; 2031 ($ Million)

Table 16 Global Enteral Feeding Formulas Market Value, By End-User, 2022-2031 ($ Million)

Table 17 Global Enteral Feeding Formulas Market Value, By Region, 2023,2027 &amp; 2031 ($ Million)

Table 18 Global Enteral Feeding Formulas Market Value, By Region, 2022-2031 ($ Million)

Table 19 North America Enteral Feeding Formulas Market Value, By Product, 2022-2031 ($ Million)

Table 20 North America Enteral Feeding Formulas Market Value, By Stage, 2022-2031 ($ Million)

Table 21 North America Enteral Feeding Formulas Market Value, By Flow Type, 2022-2031 ($ Million)

Table 22 North America Enteral Feeding Formulas Market Value, By Application, 2022-2031 ($ Million)

Table 23 North America Enteral Feeding Formulas Market Value, By End-User, 2022-2031 ($ Million)

Table 24 North America Enteral Feeding Formulas Market Value, By Country, 2022-2031 ($ Million)

Table 25 South America Enteral Feeding Formulas Market Value, By Product, 2022-2031 ($ Million)

Table 26 South America Enteral Feeding Formulas Market Value, By Stage, 2022-2031 ($ Million)

Table 27 South America Enteral Feeding Formulas Market Value, By Flow Type, 2022-2031 ($ Million)

Table 28 South America Enteral Feeding Formulas Market Value, By Application, 2022-2031 ($ Million)

Table 29 South America Enteral Feeding Formulas Market Value, By End-User, 2022-2031 ($ Million)

Table 30 South America Enteral Feeding Formulas Market Value, By Country, 2022-2031 ($ Million)

Table 31 Europe Enteral Feeding Formulas Market Value, By Product, 2022-2031 ($ Million)

Table 32 Europe Enteral Feeding Formulas Market Value, By Stage, 2022-2031 ($ Million)

Table 33 Europe Enteral Feeding Formulas Market Value, By Flow Type, 2022-2031 ($ Million)

Table 34 Europe Enteral Feeding Formulas Market Value, By Application, 2022-2031 ($ Million)

Table 35 Europe Enteral Feeding Formulas Market Value, By End-User, 2022-2031 ($ Million)

Table 36 Europe Enteral Feeding Formulas Market Value, By Country, 2022-2031 ($ Million)

Table 37 Asia-Pacific Enteral Feeding Formulas Market Value, By Product, 2022-2031 ($ Million)

Table 38 Asia-Pacific Enteral Feeding Formulas Market Value, By Stage, 2022-2031 ($ Million)

Table 39 Asia-Pacific Enteral Feeding Formulas Market Value, By Flow Type, 2022-2031 ($ Million)

Table 40 Asia-Pacific Enteral Feeding Formulas Market Value, By Application, 2022-2031 ($ Million)

Table 41 Asia-Pacific Enteral Feeding Formulas Market Value, By End-User, 2022-2031 ($ Million)

Table 42 Asia-Pacific Enteral Feeding Formulas Market Value, By Country, 2022-2031 ($ Million)

Table 43 Middle East &amp; Africa Enteral Feeding Formulas Market Value, By Product, 2022-2031 ($ Million)

Table 44 Middle East &amp; Africa Enteral Feeding Formulas Market Value, By Stage, 2022-2031 ($ Million)

Table 45 Middle East &amp; Africa Enteral Feeding Formulas Market Value, By Flow Type, 2022-2031 ($ Million)

Table 46 Middle East &amp; Africa Enteral Feeding Formulas Market Value, By Application, 2022-2031 ($ Million)

Table 47 Middle East &amp; Africa Enteral Feeding Formulas Market Value, By End-User, 2022-2031 ($ Million)

Table 48 Abbott Laboratories: Overview

Table 49 Abbott Laboratories: Product Portfolio

Table 50 Abbott Laboratories: Key Developments

Table 51 Fresenius Kabi AG: Overview

Table 52 Fresenius Kabi AG: Product Portfolio

Table 53 Fresenius Kabi AG: Key Developments

Table 54 B. Braun Melsungen AG: Overview

Table 55 B. Braun Melsungen AG: Product Portfolio

Table 56 B. Braun Melsungen AG: Key Developments

Table 57 Victus, Inc.: Overview

Table 58 Victus, Inc.: Product Portfolio

Table 59 Victus, Inc.: Key Developments

Table 60 Danone S.A.: Overview

Table 61 Danone S.A.: Product Portfolio

Table 62 Danone S.A.: Key Developments

Table 63 Nestl&eacute; S.A.: Overview

Table 64 Nestl&eacute; S.A.: Product Portfolio

Table 65 Nestl&eacute; S.A.: Key Developments

Table 66 Mead Johnson Nutrition Company: Overview

Table 67 Mead Johnson Nutrition Company: Product Portfolio

Table 68 Mead Johnson Nutrition Company: Key Developments

Table 69 Hormel Foods Corporation: Overview

Table 70 Hormel Foods Corporation: Product Portfolio

Table 71 Hormel Foods Corporation: Key Developments

Table 72 Global Health Products, Inc.: Overview

Table 73 Global Health Products, Inc.: Product Portfolio

Table 74 Global Health Products, Inc.: Key Developments

Table 75 Meiji Holdings Co., Ltd.,: Overview

Table 76 Meiji Holdings Co., Ltd.,: Product Portfolio

Table 77 Meiji Holdings Co., Ltd.,: Key Developments

&nbsp;List of Figures

Figure 1 Global Enteral Feeding Formulas Market Share, By Product, 2022 &amp; 2031 (%)

Figure 2 Global Enteral Feeding Formulas Market Share, By Stage, 2022 &amp; 2031 (%)

Figure 3 Global Enteral Feeding Formulas Market Share, By Flow Type, 2022 &amp; 2031 (%)

Figure 4 Global Enteral Feeding Formulas Market Share, By Application, 2022 &amp; 2031 (%)

Figure 5 Global Enteral Feeding Formulas Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 6 Global Enteral Feeding Formulas Market Share, By Region, 2022 &amp; 2031 (%)

Figure 7 Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 8 Global Enteral Feeding Formulas Market Y-o-Y Growth, By Product, 2022-2031 (%)

Figure 9 Standard Formulas: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 10 Disease-specific Formulas: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 11 Global Enteral Feeding Formulas Market Y-o-Y Growth, By Stage, 2022-2031 (%)

Figure 12 Adults: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 13 Pediatrics: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 14 Global Enteral Feeding Formulas Market Y-o-Y Growth, By Flow Type, 2022-2031 (%)

Figure 15 Intermittent Feeding Flow: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 16 Continuous Feeding Flow: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 17 Global Enteral Feeding Formulas Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 18 Oncology: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 19 Diabetes: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 20 Neurology: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 21 Gastroenterology: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 22 Critical Care: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 23 Others: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 24 Hospitals: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 25 Homecare Agencies &amp; Hospices: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 26 Long-term Care Facilities: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 27 Nursing Homes: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 28 Others: Global Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 29 Global Enteral Feeding Formulas Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 30 North America Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 31 North America Enteral Feeding Formulas Market Share, By Product, 2022 &amp; 2031 (%)

Figure 32 North America Enteral Feeding Formulas Market Share, By Stage, 2022 &amp; 2031 (%)

Figure 33 North America Enteral Feeding Formulas Market Share, By Flow Type, 2022 &amp; 2031 (%)

Figure 34 North America Enteral Feeding Formulas Market Share, By Application, 2022 &amp; 2031 (%)

Figure 35 North America Enteral Feeding Formulas Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 36 North America Enteral Feeding Formulas Market Share, By Country, 2022 &amp; 2031 (%)

Figure 37 South America Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 38 South America Enteral Feeding Formulas Market Share, By Product, 2022 &amp; 2031 (%)

Figure 39 South America Enteral Feeding Formulas Market Share, By Stage, 2022 &amp; 2031 (%)

Figure 40 South America Enteral Feeding Formulas Market Share, By Flow Type, 2022 &amp; 2031 (%)

Figure 41 South America Enteral Feeding Formulas Market Share, By Application, 2022 &amp; 2031 (%)

Figure 42 South America Enteral Feeding Formulas Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 43 South America Enteral Feeding Formulas Market Share, By Country, 2022 &amp; 2031 (%)

Figure 44 Europe Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 45 Europe Enteral Feeding Formulas Market Share, By Product, 2022 &amp; 2031 (%)

Figure 46 Europe Enteral Feeding Formulas Market Share, By Stage, 2022 &amp; 2031 (%)

Figure 47 Europe Enteral Feeding Formulas Market Share, By Flow Type, 2022 &amp; 2031 (%)

Figure 48 Europe Enteral Feeding Formulas Market Share, By Application, 2022 &amp; 2031 (%)

Figure 49 Europe Enteral Feeding Formulas Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 50 Europe Enteral Feeding Formulas Market Share, By Country, 2022 &amp; 2031 (%)

Figure 51 Asia-Pacific Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 52 Asia-Pacific Enteral Feeding Formulas Market Share, By Product, 2022 &amp; 2031 (%)

Figure 53 Asia-Pacific Enteral Feeding Formulas Market Share, By Stage, 2022 &amp; 2031 (%)

Figure 54 Asia-Pacific Enteral Feeding Formulas Market Share, By Flow Type, 2022 &amp; 2031 (%)

Figure 55 Asia-Pacific Enteral Feeding Formulas Market Share, By Application, 2022 &amp; 2031 (%)

Figure 56 Asia-Pacific Enteral Feeding Formulas Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 57 Asia-Pacific Enteral Feeding Formulas Market Share, By Country, 2022 &amp; 2031 (%)

Figure 58 Middle East &amp; Africa Enteral Feeding Formulas Market Value, 2022-2031 ($ Million)

Figure 59 Middle East &amp; Africa Enteral Feeding Formulas Market Share, By Product, 2022 &amp; 2031 (%)

Figure 60 Middle East &amp; Africa Enteral Feeding Formulas Market Share, By Stage, 2022 &amp; 2031 (%)

Figure 61 Middle East &amp; Africa Enteral Feeding Formulas Market Share, By Flow Type, 2022 &amp; 2031 (%)

Figure 62 Middle East &amp; Africa Enteral Feeding Formulas Market Share, By Application, 2022 &amp; 2031 (%)

Figure 63 Middle East &amp; Africa Enteral Feeding Formulas Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 64 Abbott Laboratories: Financials

Figure 65 Fresenius Kabi AG: Financials

Figure 66 B. Braun Melsungen AG: Financials

Figure 67 Victus, Inc.: Financials

Figure 68 Danone S.A.: Financials

Figure 69 Nestl&eacute; S.A.: Financials

Figure 70 Mead Johnson Nutrition Company: Financials

Figure 71 Hormel Foods Corporation: Financials

Figure 72 Global Health Products, Inc.: Financials

Figure 73 Meiji Holdings Co., Ltd.,: Financials